欧美成一级-欧美成在人线a免费-欧美传媒影-欧美大逼逼-欧美大成色www永久网站婷-欧美大胆a级视频

Gene Therapy
The Gene Editing Technology Innovation Platform
Hematopoietic Stem Cell Platform

Gene Editing Technology Innovation Platform

Gene Editing Technology Innovation Platform

The Gene Editing Technology Innovation Platform (CRISTARS®) is dedicated to developing international leading gene editing tools, obtaining core technologies with independent intellectual property rights, and paving the important foundation for gene editing technology translation. The platform is based on the combination of different single-stranded DNA deaminase structural domains and Cas9 nickase to develop a new generation of DNA base editing tools for broader and more accurate gene editing. The platform has successfully created the world-leading dual base editor and the ultra-high activity cytidine single-base editor (hyper CBE, HyCBE), which can efficiently convert two bases, improve editing activity and broaden the target range. The research results have been published in high-impact peer-review journals such as Nature Biotechnology, Nature Cell Biology, and Cell Research.

World's first successful application of CRISPR/Cas9 for mammalian gene editing

Gene editing is a technology to modify genes with precise modifications, which can be achieved with high efficiency and specificity for specific genomic DNA (or RNA), just as freely and accurately as editing text. In August 2013, a team of Bioraylab scientists published in the prestigious international journal Nature Biotechnology (IF≈43.11) the description of The CRISPR/Cas9 system was successfully used to edit genes in mice and rats. In the years since, Bioraylab scientists have continued to improve the gene editing system, applying it to a variety of applications including gene therapy, cell therapy and humanized animals.

The development of the era of gene therapy

In 2023, the world's first all human targeted BCMA CAR-T therapy "FUCASO" (Equecabtagene Autoleucel) was approved for sale in China for the treatment of recurrent or refractory multiple myeloma (R/R MM)
In 2022, Cilta cel, the first CAR-T cell therapy for the treatment of r/r MM in China, was approved by the FDA for marketing
In 2021, China's first CAR-T product, Aquilensai injection, was approved for marketing by the Chinese NMPA for post-treatment relapsed or refractory diffuse large B-cell lymphoma (DLBCL)
In 2020，CRISPR/Cas9 gene editing technology wins Nobel Prize in Chemistry
In June 2019, zynteglo, the world's first gene therapy drug ,was approved for marketing by the EU EMA for the treatment of thalassemia
In May 2019, Zolgensma, the world's first gene therapy drug,was approved for marketing by the FDA for the treatment of SMA
In 2018, the first CRISPR/Cas9-based in vivo gene therapy clinical trial (EDIT-101) was approved by the FDA for the treatment of Leber Congenital Amaurosis Type 10 (LCA)
In 2017, Kymriah, the world's first CAR-T product, received FDA approval to market for the treatment of relapsed or refractory acute lymphoblastic leukemia (ALL)
In 2016, the first generation of single-base editors were developed
In November 2013, the third generation gene editing technology CRISPR/Cas9 (clustered regularly spaced short palindromic repeats) was introduced
In 2012, Glybera, the world's first AAV gene therapy drug, was approved for marketing by the EU EMA for the treatment of lipoprotein lipase deficiency (LPLD)
In 2010, TALENs (transcription activation-like effector nucleases), a second-generation gene editing technology, was introduced
In 2003, Gendicine, the world's first gene therapy drug, was approved for marketing by the NMPA in China for the treatment of head and neck squamous cell carcinoma (HNSCC)
In 2001, the first generation of gene editing technology ZFNs (zinc finger nucleases) was introduced
In 1990, the world's first clinical trial of gene therapy was approved by the FDA for the treatment of adenosine deaminase deficiency (ADA-SCID)
Back to top
主站蜘蛛池模板： 欧美日韩亚洲另类 | 国产在线麻豆自在拍91精品 | 亚洲av影视| 国产精品自在线拍国产手 | 国产乱女乱子视频在线播放 | 精品一区二区日本高清 | 亚洲va无码专区在线观看 | 亚洲午夜国产精品无码老牛影视 | 91精品在线观看国产 | 午夜影视网 | 中文字幕精品人妻一区二区 | 国产特级婬片免费看 | 日韩高清欧美激情 | 欧美高清一区二区三区欧美 | 国产精品资源在线播放 | 精品国产自在现线看 | 国产成a| 久久夜色精品国产亚洲鲁大师 | 成人深夜福利在 | 久久视频在线 | 精品日韩在线一区二区 | 亚洲视频爱黄在线观看 | 国产一级黄在线观看免费 | 免费人妻精品一区二区三区四 | 99re欧美 | 国产在线观看无码不卡 | 自在精品久久 | 日本护士色系亚洲精品国产精品 | 又粗又硬又大又黄的免费视频 | 欧美精品一区二区 | 好看的韩国欧美大片 | 精品久久国产视频 | 亚洲另类熟女字幕 | 亚洲自偷自偷偷色无码中文 | 久久久黄色片 | 一天不日就痒痒 | 黄aaaa大片在线观看 | 久久亚洲欧洲国产 | 成人精品电影久久精品电影 | 欧美成人精品a∨在线观看 欧美成人精品第一区 | 精品国内a人片在线观看 |